GZMA
Granzyme A
Also known as: CTLA3, GRAA_HUMAN, HFSP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12544
- Gene
- GZMA
- Ensembl
- ENSG00000145649
- Chromosome
- 5
- Canonical length
- 262 aa
- Protein class
- Enzymes, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here is a T cell- and natural killer cell-specific serine protease that may function as a common component necessary for lysis of target cells by cytotoxic T lymphocytes and natural killer cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
262 residues, UniProt reviewed canonical sequence.
>P12544|GZMA
1 MRNSYRFLAS SLSVVVSLLL IPEDVCEKII GGNEVTPHSR PYMVLLSLDR KTICAGALIA
61 KDWVLTAAHC NLNKRSQVIL GAHSITREEP TKQIMLVKKE FPYPCYDPAT REGDLKLLQL
121 MEKAKINKYV TILHLPKKGD DVKPGTMCQV AGWGRTHNSA SWSDTLREVN ITIIDRKVCN
181 DRNHYNFNPV IGMNMVCAGS LRGGRDSCNG DSGSPLLCEG VFRGVTSFGL ENKCGDPRGP
241 GVYILLSKKH LNWIIMTIKG AVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GZMA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 64 nTPM
- spleen: 48 nTPM
- bone marrow: 33 nTPM
- duodenum: 28 nTPM
- small intestine: 26 nTPM
- lung: 21 nTPM
Single-cell type
- nk-cells: 1,125 nCPM
- t-cells: 478 nCPM
- innate lymphoid cells: 19 nCPM
- pdcs: 10 nCPM
- neutrophil progenitors: 9.4 nCPM
- submucosal glandular cells: 7.7 nCPM
Immune cell
- gdT-cell: 944 nTPM
- MAIT T-cell: 928 nTPM
- memory CD8 T-cell: 923 nTPM
- NK-cell: 721 nTPM
- total PBMC: 713 nTPM
- naive CD8 T-cell: 496 nTPM
Brain region
- medulla oblongata: 1.8 nTPM
- choroid plexus: 1.1 nTPM
- white matter: 0.9 nTPM
- pons: 0.8 nTPM
- spinal cord: 0.8 nTPM
- thalamus: 0.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cytotoxic T cell pyroptotic cell death
- granzyme-mediated programmed cell death signaling pathway
- immune response
- killing of cells of another organism
- negative regulation of DNA binding
- negative regulation of oxidoreductase activity
- positive regulation of apoptotic process
- protein maturation
- proteolysis involved in protein catabolic process
- pyroptotic inflammatory response
- response to bacterium
- negative regulation of endodeoxyribonuclease activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GZMA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GZMA as an antibody target. Whether an autoantibody or antibody against GZMA could matter depends on whether native GZMA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GZMA is annotated as secreted, so native GZMA circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GZMA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...